C12Y 305/01001
Asparaginase
Official title: Asparaginase (3.5.1.1)
C12Y305/01001 (Asparaginase) appears on 115 US grants and 232 published applications in this corpus.
Search patents in C12Y- Granted patents
- 115
- Published applications
- 232
- Assignees
- 119
- Inventors
- 424
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 3 |
| 2003 | 0 | 1 |
| 2004 | 0 | 12 |
| 2005 | 0 | 3 |
| 2006 | 2 | 2 |
| 2007 | 1 | 3 |
| 2008 | 1 | 5 |
| 2009 | 3 | 5 |
| 2010 | 2 | 6 |
| 2011 | 4 | 5 |
| 2012 | 6 | 10 |
| 2013 | 4 | 5 |
| 2014 | 3 | 14 |
| 2015 | 4 | 12 |
| 2016 | 4 | 22 |
| 2017 | 9 | 14 |
| 2018 | 8 | 13 |
| 2019 | 16 | 19 |
| 2020 | 7 | 16 |
| 2021 | 10 | 9 |
| 2022 | 5 | 17 |
| 2023 | 7 | 8 |
| 2024 | 4 | 8 |
| 2025 | 7 | 12 |
| 2026 | 2 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for treating cancer31 Mar 2026US 12,590,966 B2Children's Medical Center Corporation
- Dosing and administration of recombinant L-asparaginase17 Feb 2026US 12,551,540 B2Jazz Pharmaceuticals Ireland Limited
- Methods related to administering immunosuppressants and non-allergenic antigens to reduce or prevent anaphylaxis30 Dec 2025US 12,508,249 B2Cartesian Therapeutics, Inc.
- Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both Type 1 and Type IV hypersensitivity18 Nov 2025US 12,472,167 B2Cartesian Therapeutics, Inc.
- Method of treating AML with PEGylated l-asparaginase14 Oct 2025US 12,441,992 B2Jazz Pharmaceuticals II SAS
- Dosing and administration of recombinant l-asparaginase11 Jun 2026US 2026/0158122 A1Jazz Pharmaceuticals Ireland Limited
- Method for treating cancer4 Jun 2026US 2026/0151467 A1Children's Medical Center Corporation
- Non-fouling or super stealth vesicle7 May 2026US 2026/0124140 A1Kawasaki Institute of Industrial Promotion
- Method for treating cancer by using combination of asparagine inhibitor and immune checkpoint inhibitor and pharmaceutical composition comprising combination of asparagine inhibitor and immune checkpoint inhibitor30 Apr 2026US 2026/0115283 A1Chang Gung Memorial Hospital, Linkou
- Functionalized biocatalytical compositions9 Apr 2026US 2026/0097103 A1Perseo Pharma AG
Most cited
By later US patents
- Antitumour compositions containing taxane derivatives61US 5,728,687 ARhone-Poulenc Rorer S.A. · 1998
- Anti-tumor compositions containing taxane derivatives54US 5,908,835 ARhone-Poulenc Rorer S.A. · 1999
- Variant activin receptor polypeptides and uses thereof51US 8,999,917 B2Amgen Inc. · 2015
- Targeting conjugates of albumin and therapeutic agents46US 4,749,570 AThe Governors of the University of Alberta · 1988
- Antitumor compositions containing taxane derivatives41US 6,214,863 B1Aventis Pharma S. A. · 2001